Advanced Analytics
Get next-level healthcare insights
Company profile
Company profile
Definitive Healthcare is a leading data and analytics company specializing in the business side of healthcare. The company cuts through the complexity of the healthcare market to deliver actionable insights that enable smarter, faster, and more strategic decision-making across the healthcare ecosystem. Definitive Healthcare serves multiple industries including biopharma, medtech, healthcare providers, software and IT, consulting and financial services, and other healthcare-adjacent sectors. The company's comprehensive platform includes several flagship products: HospitalView for hospital and IDN insights covering 9,000+ facilities, PhysicianView with data on over 3 million healthcare professionals, Atlas All-Payor and Prescription Claims providing billions of insurance claims, and the Monocl suite for identifying medical experts and KOLs globally. Additional solutions include Populi for claims and consumer analytics with privacy-safe HCP and DTC targeting, and Carevoyance for sales enablement. The company's proprietary Atlas Dataset and Definitive ID system provide a unified view across the healthcare landscape, integrating data from public, private, and proprietary sources. Definitive Healthcare's technology enables use cases spanning go-to-market strategy, product development, market intelligence, corporate development, and sales optimization. The company emphasizes data transparency, reliability, and healthcare specialization, positioning itself as a trusted partner for organizations seeking to understand clinical trends, identify experts, drive engagement, improve market access, and build smarter strategies. By providing clarity to the complex healthcare market, Definitive Healthcare helps its clients succeed in ways that ultimately improve healthcare for everyone.
Company description Definitive Healthcare official website
Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
No clinical focus areas are currently listed.
Api Only · Cloud Saas · Other deployment with recorded integration context.
02 · Flagship portfolio
Selected source-backed Company products and the available commercial context.
Get next-level healthcare insights
Gain insights using medical & prescription claims
Access billions of distinct prescription claims
Accelerate your revenue growth
Understand complex affiliations and partnerships
Enrich your systems with our data
Privacy-safe HCP and DTC targeting
Access powerful hospital & IDN insights
Understand your market and trends
03 · Research intelligence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Journal of the American Heart Association · Jul 25, 2026
Vutrisiran Health Care Resource Utilization, Costs, Discontinuation, and Mortality: A Real-World Claims Analysis.Advances in therapy · Jul 15, 2026
Contemporary Oral Medication Use and Frequency in Patients with Transthyretin Amyloid Cardiomyopathy.American journal of cardiovascular drugs : drugs, devices, and other interventions · Nov 1, 2025
Social Media Insights Into Disease Burden in Patients and Caregivers of Myelodysplastic Syndrome: Subcohort Analysis of High-Risk Patients.Journal of medical Internet research · Aug 22, 2025
The spatiotemporal distribution of human pathogens in ancient Eurasia.Nature · Jul 1, 2025
A Virtual, Randomized, Control Trial of a Digital Therapeutic for Speech, Language, and Cognitive Intervention in Post-stroke Persons With Aphasia.Frontiers in neurology · Jan 1, 2021
Clinical validation
No linked records are currently available.
Regulatory
No linked records are currently available.
04 · Company-reported outcomes
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
Oncology medical device company identified over 900 KOLs quickly, accelerating physician and healthcare organization interest
Considerable time saved by accessing market- and physician-level data in one place
Increased accuracy of targeting for tailored outreach in specialized markets
Improving sales strategy by understanding healthcare organization relationships, tracking buying patterns, and refining sales strategies
Building a key opinion leader network for new product launch. The company needed to identify experts and build a KOL network before commercial launch, with limited insight into their addressable market.
Quickly identified over 900 KOLs, increased accuracy of targeting, and accelerated physician and healthcare organization interest to set foundation for strong sales pipeline
05 · Leadership
Leadership profiles and professional links from the current Company record.
No active leadership profiles are currently listed.
06 · Company updates
Recent articles published on Definitive Healthcare's official website.
No Company updates are currently listed.
07 · HAIC coverage
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Curated official destinations from the active Company record.
09 · Market pathway
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Companies providing AI-powered analytics for population health management, healthcare data integration and analysis, risk stratification, care gap identification, or value-based care analytics. Focuses on analyzing data across patient populations to improve outcomes at scale and enable data-driven decision-making across health systems.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market10 · Pro research
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.